Employees
NAT Tests
Cities
Employees
NAT Tests
Cities
The force behind India’s most advanced health screening solutions
At Hemogenomics, diagnosis and disease prevention are at the heart of everything we do. That’s why we’ve committed ourselves to making cutting-edge healthcare technology available in India. We do this in collaboration with global leaders to enable better screening for better health.
Blood Screening
We are the forerunners of ID-NAT (Individual Donor Nucleic Acid Testing) technology in India, which is used to screen donated blood. Our NAT installation base is the largest in the country.
Read MoreCancer Screening
Cervical cancer is curable if detected early on. And we are determined to make a paradigm shift in the early detection of cancer by bringing appropriate technologies to India and saving lives with timely diagnosis.
Read MoreHear It From Our Customers
Our customer stories reflect our relentless pursuit of contributing to India’s healthcare system.
Dr Mohit Chowdhry
Sr. Consultant & Coordinator,
Department of Transfusion Medicine, Molecular Biology & Transplant Immunology, Indraprastha Apollo Hospital, New Delhi
“The introduction of Individual Donor Nucleic Acid Testing (ID-NAT) in our blood bank has made it possible to accurately detect the presence of possible viruses, namely HIV and Hepatitis in the donated blood.”
Dr Anand Deshpande
Consultant,
Department of Transfusion Medicine, P.D Hinduja National Hospital & Medical Research Centre, Mumbai
“Our goal is zero risk blood supply. With ID-NAT, we have come one step closer to zero risk.”
Dr Aseem Tiwari
Directo,r
Department of Laboratory Medicine, Pathology & Blood Bank, Medanta - The Medicity, Gurugram
“ID-NAT offers uncompromised sensitivity and can detect infection even when the viral load is very low.”
Dr Rajesh Sawant
Consultant,
Department of Transfusion Medicine, Kokilaben Dhirubhai Ambani Hospital & Medical Research Institute, Mumbai
“ID-NAT works by reducing the window period for infection and offers uncompromised sensitivity, even in samples with low viral load.”
Dr Veena Shenoy
Clinical Associate Professor,
Department of Transfusion Medicine, Amrita Institute of Medical Sciences & Research Centre, Kochi
“We were the first in Kerala to adopt ID-NAT for screening of blood. When patient safety is of paramount importance, we never compromise on technology and testing methodology.”
Dr Deepa Bhuyan
Medical Officer In-charge
Department of Transfusion Medicine, Apollo Hospital, Guwahati
“We are glad that the after-sales service offered by Hemogenomics is excellent.”
Dr Anand Chaphekar
Chief Blood Transfusion Officer and In-charge,KEM Hospital, Pune
“I am convinced about the array of benefits that ID-NAT offers to patients in our hospital and would recommend the use of this technology to other blood banks.”
Dr Dhinesh Kumar
Senior Specialist - Blood Bank,
Aster Medcity, Kochi
“As ID-NAT tests all samples individually, the chances of false positive results are less and there is no extra time consumed in deconvolution, which further ensures timely delivery of results.”
Dr Archana Bajpayee
Associate Professor,
All India Institute of Medical Sciences, Jodhpur
“Other than having a shorter window period, ID-NAT has the ability to detect even viral mutants which may otherwise get missed out by conventional tests.”
Dr Gita Negi
Additional Professor,
Department of Transfusion Medicine, All India Institute of Medical Sciences, Rishikesh
“We have been using ID-NAT for screening of blood. We are glad that through this technology, we can ensure optimum safety of patients visiting our hospital. ”
Dr Gita Negi
Additional Professor and HOD,
Department of Transfusion Medicine, All India Institute of Medical Sciences, Rishikesh
“We have been using ID-NAT for screening of blood. We are glad that through this technology, we can ensure optimum safety of patients visiting our hospital. ”
Dr Archana Bajpayee
Additional Professor,
All India Institute of Medical Sciences, Jodhpur
“Other than having a shorter window period, ID-NAT has the ability to detect even viral mutants which may otherwise get missed out by conventional tests.”
Dr Dhinesh Kumar
Senior Specialist - Blood Bank,
Aster Medcity, Kochi
“As ID-NAT tests all samples individually, the chances of false positive results are less and there is no extra time consumed in deconvolution, which further ensures timely delivery of results.”
Dr Anand Chaphekar
Chief Blood Transfusion Officer and In-charge, KEM Hospital, Pune
“I am convinced about the array of benefits that ID-NAT offers to patients in our hospital and would recommend the use of this technology to other blood banks.”
Dr Deepa Bhuyan
Medical Officer In-charge,
Department of Transfusion Medicine, Apollo Hospital, Guwahati
“We are glad that the after-sales service offered by Hemogenomics is excellent.”
Dr Veena Shenoy
Clinical Associate Professor,
Department of Transfusion Medicine, Amrita Institute of Medical Sciences & Research Centre, Kochi
“We were the first in Kerala to adopt ID-NAT for screening of blood. When patient safety is of paramount importance, we never compromise on technology and testing methodology.”
Dr Rajesh Sawant
Consultant,
Department of Transfusion Medicine, Kokilaben Dhirubhai Ambani Hospital & Medical Research Institute, Mumbai
“ID-NAT works by reducing the window period for infection and offers uncompromised sensitivity, even in samples with low viral load.”
Dr Aseem Tiwari
Director,
Department of Laboratory Medicine, Pathology & Blood Bank, Medanta - The Medicity, Gurugram
“ID-NAT offers uncompromised sensitivity and can detect infection even when the viral load is very low.”
Dr Anand Deshpande
Consultant,
Department of Transfusion Medicine, P.D Hinduja National Hospital & Medical Research Centre, Mumbai
“Our goal is zero risk blood supply. With ID-NAT, we have come one step closer to zero risk.”
Dr Mohit Chowdhry
Sr. Consultant & Coordinator,
Department of Transfusion Medicine, Molecular Biology & Transplant Immunology, Indraprastha Apollo Hospital, New Delhi
“The introduction of Individual Donor Nucleic Acid Testing (ID-NAT) in our blood bank has made it possible to accurately detect the presence of possible viruses, namely HIV and Hepatitis in the donated blood.”